Cite
HARVARD Citation
Janning, M. et al. (2019). Evaluation of soluble carbonic anhydrase IX as predictive marker for efficacy of bevacizumab: A biomarker analysis from the geparquinto phase III neoadjuvant breast cancer trial. International journal of cancer. 145 (3), pp. 857-868. [Online].